Matthew J. Dowd and Hon. Paul R. Michel (Ret.) Discuss Biotech Patent Eligibility
In a recent IPWatchdog article, Judge Paul R. Michel (Ret.) and Matthew J. Dowd revisit the landmark Diamond v. Chakrabarty decision and its relevance to today’s biotech innovations. The article analyzes the Federal Circuit appeal in Regenxbio v. Sarepta, where the court must decide whether a man-made host cell qualifies as patent eligible under Section 101. Drawing on precedent from Chakrabarty and Myriad , Dowd and Judge Michel emphasize why maintaining strong patent prote
Nov 19
USPTO Cites Michel & Dowd Article in Proposed Rulemaking on PTAB Changes
In October 2025, the USPTO issued a notice of proposed rulemaking (“NPRM”) to revise procedures for IPRs before the PTAB. In the NPRM, the USPTO cited and quoted the article Patent Protection: A Crucial Antitrust Tool for Increasing Innovation , authored by the Honorable Paul R. Michel (ret.) and Dowd Scheffel partner Matthew J. Dowd . The USPTO referenced the article to underscore the importance of reliable patent rights in fostering innovation and economic growth, partic
Oct 20
Dowd Scheffel Files Amicus Brief for Former Fed Cir Judges and Others
On July 18, 2025, Dowd Scheffel PLLC filed an amicus curiae brief on behalf of a distinguished group of former federal judges, a former...
Jul 21
Dowd Scheffel PLLC Urges Court to Reconsider Key Design-Patent Infringement Test
Dowd Scheffel PLLC, on behalf of client North Star Technology International Ltd., filed a petition for en banc rehearing at the U.S....
Jun 29
Dowd Scheffel Client Prevails in Federal Circuit Appeal, Securing Reversal in High-Stakes False Advertising Case
In a major appellate victory, Dowd Scheffel successfully represented ThermoLife International LLC, Ronald Kramer, and Muscle Beach...
Jun 16
Dowd Scheffel Quoted About Recent En Banc Rehearing
In a recent analysis of the Google v. EcoFactor en banc rehearing, Managing Partner Matthew Dowd shared his insights on the...
Mar 20